245 related articles for article (PubMed ID: 11200439)
1. [Blood protein technological industrial developments as a mirror of fundamental studies bgy the Institute of Biochemistry of the Ukrainian National Academy of Sciences].
Volkov GL; Andrianov SI; Horoshnykova TV; Borysevych OS; Gavryliuk OS
Ukr Biokhim Zh (1999); 2000; 72(4-5):109-21. PubMed ID: 11200439
[TBL] [Abstract][Full Text] [Related]
2. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
Burnouf T; Michalski C; Goudemand M; Huart JJ
Vox Sang; 1989; 57(4):225-32. PubMed ID: 2617959
[TBL] [Abstract][Full Text] [Related]
3. Large-scale production and properties of a solvent-detergent-treated factor IX concentrate from human plasma.
Michalski C; Bal F; Burnouf T; Goudemand M
Vox Sang; 1988; 55(4):202-10. PubMed ID: 3265237
[TBL] [Abstract][Full Text] [Related]
4. A therapeutic, highly purified factor XI concentrate from human plasma.
Burnouf-Radosevich M; Burnouf T
Transfusion; 1992; 32(9):861-7. PubMed ID: 1471251
[TBL] [Abstract][Full Text] [Related]
5. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
6. Progress in purification of virus-inactivated factor VIII concentrates. Three generations of solvent/detergent treated plasma derivatives.
Schwinn H; Smith A; Wolter D
Arzneimittelforschung; 1989 Oct; 39(10):1302-5. PubMed ID: 2514695
[TBL] [Abstract][Full Text] [Related]
7. Chromatographic purification and properties of a therapeutic human protein C concentrate.
Radosevich M; Zhou FL; Huart JJ; Burnouf T
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 790(1-2):199-207. PubMed ID: 12767332
[TBL] [Abstract][Full Text] [Related]
8. Large-scale preparation and biochemical characterization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography.
Feldman PA; Bradbury PI; Williams JD; Sims GE; McPhee JW; Pinnell MA; Harris L; Crombie GI; Evans DR
Blood Coagul Fibrinolysis; 1994 Dec; 5(6):939-48. PubMed ID: 7893930
[TBL] [Abstract][Full Text] [Related]
9. Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate.
Burnouf-Radosevich M; Burnouf T
Vox Sang; 1992; 62(1):1-11. PubMed ID: 1580062
[TBL] [Abstract][Full Text] [Related]
10. Purification of human factor IX by chromatography of a coagulation factor concentrate.
Suomela H
Thromb Haemost; 1976 Feb; 35(1):211-21. PubMed ID: 989188
[TBL] [Abstract][Full Text] [Related]
11. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
[TBL] [Abstract][Full Text] [Related]
12. Large-scale preparation of thrombin from human plasma.
Aizawa P; Winge S; Karlsson G
Thromb Res; 2008; 122(4):560-7. PubMed ID: 18329699
[TBL] [Abstract][Full Text] [Related]
13. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
14. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII:c concentrate virus inactivated: progress in purification by using classic chromatographic methods.
Arrighi S; Pacenti L; Borri MG
Vox Sang; 1993; 64(1):13-8. PubMed ID: 8447116
[TBL] [Abstract][Full Text] [Related]
16. Proteomics as a tool for optimization of human plasma protein separation.
Kovac S; Yang X; Huang F; Hixson D; Josic D
J Chromatogr A; 2008 Jun; 1194(1):38-47. PubMed ID: 18486944
[TBL] [Abstract][Full Text] [Related]
17. Immunoaffinity purification of factor IX from commercial concentrates and infusion studies in animals.
Smith KJ
Blood; 1988 Oct; 72(4):1269-77. PubMed ID: 3262386
[TBL] [Abstract][Full Text] [Related]
18. Preparation of factor VII concentrate using CNBr-activated Sepharose 4B immunoaffinity chromatography.
Mousavi Hosseini K; Nasiri S
Med J Islam Repub Iran; 2015; 29():170. PubMed ID: 26034723
[TBL] [Abstract][Full Text] [Related]
19. Progress in large-scale purification of factor VIII/von Willebrand factor concentrates using ion-exchange chromatography.
Mori F; Nardini I; Rossi P; Nardini C; Farina C
Vox Sang; 2008 Nov; 95(4):298-307. PubMed ID: 19138259
[TBL] [Abstract][Full Text] [Related]
20. Development, upscaling and validation of the purification process for human-cl rhFVIII (Nuwiq®), a new generation recombinant factor VIII produced in a human cell-line.
Winge S; Yderland L; Kannicht C; Hermans P; Adema S; Schmidt T; Gilljam G; Linhult M; Tiemeyer M; Belyanskaya L; Walter O
Protein Expr Purif; 2015 Nov; 115():165-75. PubMed ID: 26318235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
